Stay up-to-date with the Sun Pharma Stock Liveblog, your comprehensive source for real-time updates and detailed analysis on ...

In a dramatic change to Australian patent law, Australia's Full Federal Court has just held that patents for pharmaceutical formulations are not eligible for patent term extensions ( PTE ): Otsuka ...

Overview Neuland Labs leads the pack with an outstanding 5-year CAGR of 74.3%, supported by strong earnings and efficient ...

Ascroft succeeds Abhay Gandhi. According to a June 25 hiring announcement from the the India-based parent company Gandhi, “played a pivotal role in the growth of the Sun Pharma North America business.

SPARC: The stock jumped 20 per cent to touch its upper price band of Rs 161.10, although it remains down 19.73 per cent on a ...

Sun Pharmaceutical Industries Ltd. closed 4.12% below its 52-week high of 1,910.00 rupees, which the company achieved on ...

A trio of Indian drugmakers—Alembic Pharmaceuticals, Sun Pharmaceutical and Glenmark Pharmaceuticals—issued separate voluntary U.S. drug recalls in recent weeks due to either the presence of ...

Sun Pharmaceutical Industries Limited ( ($IN:SUNPHARMA) ) just unveiled an announcement. Sun Pharmaceutical Industries Limited announced that its ...

Sun Pharma informed the stock exchanges that the board of directors of its subsidiary Sun Pharma Laboratories approved the ...

Sun Pharma is confident that its four-times-a-year psoriasis drug Ilumya and its corresponding information booth managed to stand out in the crowd at the American Academy of Dermatology Annual Meeting ...

Sun Pharmaceutical Industries Ltd. 524715 -1.28% shares inched down 0.54% to 1,798.05 Indian rupees Tuesday, on what proved ...

Welcome to the Sun Pharma Stock Liveblog, your real-time source for the latest updates and comprehensive analysis on a ...